BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36315374)

  • 21. Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery.
    Barth CW; Schaefer JM; Rossi VM; Davis SC; Gibbs SL
    Theranostics; 2017; 7(19):4722-4734. PubMed ID: 29187899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
    Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Main Specimen and Tumor Bed Margin Status With Local Recurrence and Survival in Oral Cancer Surgery.
    Buchakjian MR; Tasche KK; Robinson RA; Pagedar NA; Sperry SM
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1191-1198. PubMed ID: 27423460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis.
    Higginson JA; Breik O; Thompson AH; Ashrafian H; Hardman JC; Takats Z; Paleri V; Dhanda J
    Oral Oncol; 2023 Jul; 142():106419. PubMed ID: 37178655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
    Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
    Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
    [No Abstract]   [Full Text] [Related]  

  • 26. Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.
    Tajudeen BA; Taylor ZD; Garritano J; Cheng H; Pearigen A; Sherman AJ; Palma-Diaz F; Mishra P; Bhargava S; Pesce J; Kim I; Sebastian C; Razfar A; Papour A; Stafsudd O; Grundfest W; St John M
    Cancer; 2017 Mar; 123(5):879-886. PubMed ID: 27763689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of Frozen Section Examination in Oral Cavity Cancers.
    Demir B; Incaz S; Uckuyulu EI; Oysu C
    Ear Nose Throat J; 2022 Sep; 101(8):NP354-NP357. PubMed ID: 33155855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Sentinel Margin: Intraoperative
    van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
    Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of receptor-specific surgical specimen staining correlates with receptor expression level.
    Schaefer JM; Barth CW; Davis SC; Gibbs SL
    J Biomed Opt; 2019 Feb; 24(2):1-9. PubMed ID: 30737910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nonspecific binding of imaging agents to plasma protein in the paired-agent imaging for resection during surgery (PAIRS).
    Xu X; Tichauer KM; Samkoe KS
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11219():. PubMed ID: 34121794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma.
    Knowles JA; Heath CH; Saini R; Umphrey H; Warram J; Hoyt K; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):662-8. PubMed ID: 22801891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
    Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
    Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of intraoperative frozen section analysis on final resection margin status, recurrence, and patient outcome with oral squamous cell carcinoma.
    Nentwig K; Unterhuber T; Wolff KD; Ritschl LM; Nieberler M
    Clin Oral Investig; 2021 Dec; 25(12):6769-6777. PubMed ID: 33956217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
    Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
    Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative Tumor Assessment Using Real-Time Molecular Imaging in Head and Neck Cancer Patients.
    van Keulen S; Nishio N; Fakurnejad S; van den Berg NS; Lu G; Birkeland A; Martin BA; Forouzanfar T; Colevas AD; Rosenthal EL
    J Am Coll Surg; 2019 Dec; 229(6):560-567.e1. PubMed ID: 31568855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
    Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
    Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Rapid Analysis Method for Bone Resection Margins for Oral Squamous Cell Carcinoma by Immunoblotting.
    Haase C; Lethaus B; Knüchel-Clarke R; Hölzle F; Cassataro A; Braunschweig T
    Head Neck Pathol; 2018 Jun; 12(2):210-220. PubMed ID: 28929330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histogram analysis of synthetic magnetic resonance imaging: Correlations with histopathological factors in head and neck squamous cell carcinoma.
    Yang F; Li Y; Lei H; Wei H; Du Q; Yu X; Li X; Zhao Y; Li L; Xie L; Lin M
    Eur J Radiol; 2023 Mar; 160():110715. PubMed ID: 36753947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer.
    Vonk J; de Wit JG; Voskuil FJ; Tang YH; Hooghiemstra WTR; Linssen MD; van den Broek E; Doff JJ; de Visscher SAHJ; Schepman KP; van der Vegt B; van Dam GM; Witjes MJH
    J Nucl Med; 2022 May; 63(5):672-678. PubMed ID: 34531264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
    Wheeler S; Siwak DR; Chai R; LaValle C; Seethala RR; Wang L; Cieply K; Sherer C; Joy C; Mills GB; Argiris A; Siegfried JM; Grandis JR; Egloff AM
    Clin Cancer Res; 2012 Apr; 18(8):2278-89. PubMed ID: 22351687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.